These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32705629)

  • 1. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
    Li Y; Liu W; Saini V; Wong YH
    Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
    Wong KM; Song J; Wong YH
    Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
    Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles.
    Saini V; Do Y; Yam JWP; Wong YH
    Cell Signal; 2024 Aug; 120():111203. PubMed ID: 38723736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
    McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
    Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple regulation of metastasis suppressor NM23-H1 in cancer.
    Yu L; Wang X; Zhang W; Khan E; Lin C; Guo C
    Life Sci; 2021 Mar; 268():118995. PubMed ID: 33421524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
    Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
    Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.
    Murakami M; Meneses PI; Lan K; Robertson ES
    Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered gene and protein expression by Nm23-H1 in metastasis suppression.
    Lee JH; Marshall JC; Steeg PS; Horak CE
    Mol Cell Biochem; 2009 Sep; 329(1-2):141-8. PubMed ID: 19415462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
    Mátyási B; Farkas Z; Kopper L; Sebestyén A; Boissan M; Mehta A; Takács-Vellai K
    Pathol Oncol Res; 2020 Jan; 26(1):49-61. PubMed ID: 31993913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
    Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
    Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
    Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
    Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
    Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
    Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
    Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
    Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1.
    Chen J; Jiang Q; Jiang XQ; Li DQ; Jiang XC; Wu XB; Cao YL
    J Biochem; 2020 Jan; 167(1):41-48. PubMed ID: 31598678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
    Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
    J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulators affecting the metastasis suppressor activity of Nm23-H1.
    Kim HD; Youn B; Kim TS; Kim SH; Shin HS; Kim J
    Mol Cell Biochem; 2009 Sep; 329(1-2):167-73. PubMed ID: 19377884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.